Clinical Trial

Effects of Effera Human Lactoferrin at One Dose Compared to Placebo on Gut Permeability

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated June 25, 2025 (before its estimated August 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
The purpose of this study is to evaluate the impact of 28-day supplementation with effera human lactoferrin, compared to a placebo control product on indicators of gut barrier health in males and females
Trial Details
NCT Number NCT07035964
Lead Sponsor Helaina Inc.
Collaborators: Biofortis Mérieux NutriSciences
Conditions Gut Permeability, Gut Health
Enrollment 46 participants
Start Date 2025-06-04
Primary Completion 2025-08-30 (estimated)
Study Completion 2025-08-30 (estimated)
Updated on ClinicalTrials.gov 2025-06-25